Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1970 Sep;49(9):1694–1708. doi: 10.1172/JCI106387

Serum and urinary proteins, lysozyme (muramidase), and renal dysfunction in mono- and myelomonocytic leukemia

W Pruzanski 1,2, M E Platts 1,2
PMCID: PMC322653  PMID: 5270914

Abstract

Serum levels, urinary excretion, and clearances of several proteins of different molecular weights were studied in 18 patients with mono- and myelomonocytic leukemia. Nine patients had normal renal function (group A) and nine had impaired renal function with azotemia (group B). The majority of patients in both groups had increased concentration of immunoglobulins, particularly IgG, IgA, and IgM; IgD level was normal. Serum transferrin and α2-macroglobulin were frequently reduced while the level of ceruloplasmin was often increased, especially in patients with azotemia. The activity of lysozyme in the serum was high in all patients, but was considerably higher in group B.

Proteinuria was found in most patients but was more prominent in group B. Almost invariably albumin constituted less than 25% of the total protein excreted. Qualitative analysis of various urinary proteins by immunochemical techniques and clearance studies suggested the presence of glomerular as well as tubular dysfunction. Determination of urinary lysozyme frequently showed no direct correlation between the serum level of the enzyme and its concentration in the urine or its clearance by the kidney. In addition to glomerular filtration, impaired tubular reabsorption may account for the high level of lysozyme in the urine. It is postulated that the very high level of lysozyme in the glomerular filtrate and possibly hypergammaglobulinemia may play a role in the induction of tubular damage. Renal impairment has been correlated with histological changes in the kidneys. From a comparative study of various leukemias, it seems that the combined glomerular-tubular dysfunction is a manifestation unique to mono- and myelomonocytic leukemia.

Full text

PDF
1695

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BUTLER E. A., FLYNN F. V., HARRIS H., ROBSON E. B. A study of urine proteins by two-dimensional electrophoresis with special reference to the proteinuria of renal tubular disorders. Clin Chim Acta. 1962 Jan;7:34–41. doi: 10.1016/0009-8981(62)90113-4. [DOI] [PubMed] [Google Scholar]
  2. Bergsagel D. E. The chronic leukemias: a review of disease manifestations and the aims of therapy. Can Med Assoc J. 1967 Jun 24;96(25):1615–1620. [PMC free article] [PubMed] [Google Scholar]
  3. Charlemagne D., Jollès P. Les lysozymes des leucocytes et du plasma d'origine humaine. Hommes normaux et malades atteints de leucémie myéloïde chronique. Nouv Rev Fr Hematol. 1966 May-Jun;6(3):355–366. [PubMed] [Google Scholar]
  4. FAHEY J. L., BOGGS D. R. Serum protein changes in malignant diseases. I. The acute leukemias. Blood. 1960 Oct;16:1479–1490. [PubMed] [Google Scholar]
  5. FISHER E. R., PEREZ-STABLE E., ZAWADZKI Z. A. ULTRASTRUCTURAL RENAL CHANGES IN MULTIPLE MYELOMA WITH COMMENTS RELATIVE TO THE MECHANISM OF PROTEINURIA. Lab Invest. 1964 Dec;13:1561–1574. [PubMed] [Google Scholar]
  6. Fahey J. L. Antibodies and immunoglobulins. II. Normal development and changes in disease. JAMA. 1965 Oct 18;194(3):255–258. doi: 10.1001/jama.194.3.255. [DOI] [PubMed] [Google Scholar]
  7. GRABAR P., WILLIAMS C. A., Jr Méthode immuno-électrophorétique d'analyse de mélanges de substances antigéniques. Biochim Biophys Acta. 1955 May;17(1):67–74. doi: 10.1016/0006-3002(55)90320-6. [DOI] [PubMed] [Google Scholar]
  8. Harrison J. F., Blainey J. D. Adult Fanconi syndrome with monoclonal abnormality of immunoglobulin light chain. J Clin Pathol. 1967 Jan;20(1):42–48. doi: 10.1136/jcp.20.1.42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Harrison J. F., Lunt G. S., Scott P., Blainey J. D. Urinary lysozyme, ribonuclease, and low-molecular-weight protein in renal disease. Lancet. 1968 Feb 24;1(7539):371–375. doi: 10.1016/s0140-6736(68)91350-0. [DOI] [PubMed] [Google Scholar]
  10. Harrison J. F., Northam B. E. Low molecular weight urine protein investigated by gel filtration. Clin Chim Acta. 1966 Nov;14(5):679–688. doi: 10.1016/0009-8981(66)90195-1. [DOI] [PubMed] [Google Scholar]
  11. Hayslett J. P., Perillie P. E., Finch S. C. Urinary muramidase and renal disease. Correlation with renal histology and implication for the mechanism of enzymuria. N Engl J Med. 1968 Sep 5;279(10):506–512. doi: 10.1056/NEJM196809052791002. [DOI] [PubMed] [Google Scholar]
  12. JOACHIM G. R., CAMERON J. S., SCHWARTZ M., BECKER E. L. SELECTIVITY OF PROTEIN EXCRETION IN PATIENTS WITH THE NEPHROTIC SYNDROME. J Clin Invest. 1964 Dec;43:2332–2346. doi: 10.1172/JCI105107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Jollés P., Bonnafé M., Mouton A., Schwarzenberg L. Dosage automatique du lysozyme dans l'urine de divers leucémiques: caratérisation et purification d'un lysozyme chez les seuls malades atteints de leucémie myéloblastique aiguë. Rev Fr Etud Clin Biol. 1967 Dec;12(10):996–998. [PubMed] [Google Scholar]
  14. MARSHALL M. E., DEUTSCH H. F. Clearances of some proteins by the dog kidney. Am J Physiol. 1950 Nov;163(2):461–467. doi: 10.1152/ajplegacy.1950.163.2.461. [DOI] [PubMed] [Google Scholar]
  15. Maack T. Changes in the activity of acid hydrolases during renal reabsorption of lysozyme. J Cell Biol. 1967 Oct;35(1):268–273. doi: 10.1083/jcb.35.1.268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. MacLean P. R., Robson J. S. A simple method for determining selectivity of proteinuria. Lancet. 1967 Mar 11;1(7489):539–542. doi: 10.1016/s0140-6736(67)92116-2. [DOI] [PubMed] [Google Scholar]
  17. Morris R. C., Jr, Fudenberg H. H. Impaired renal acidification in patients with hypergammaglobulinemia. Medicine (Baltimore) 1967 Jan;46(1):57–69. doi: 10.1097/00005792-196701000-00003. [DOI] [PubMed] [Google Scholar]
  18. Muggia F. M., Heinemann H. O., Farhangi M., Osserman E. F. Lysozymuria and renal tubular dysfunction in monocytic and myelomonocytic leukemia. Am J Med. 1969 Sep;47(3):351–366. doi: 10.1016/0002-9343(69)90219-8. [DOI] [PubMed] [Google Scholar]
  19. NETTLESHIP A., STROTHER J. A., SMITH H. S. RELATIONSHIP OF SERUM AND URINARY PROTEINS IN NEOPLASTIC STATES: A PRELIMINARY SURVEY. Clin Chem. 1963 Oct;102:608–614. [PubMed] [Google Scholar]
  20. NORRIS H. J., WIENER J. The renal lesions in leukemia. Am J Med Sci. 1961 Apr;241:512–518. doi: 10.1097/00000441-196104000-00016. [DOI] [PubMed] [Google Scholar]
  21. Noble R. E., Fudenberg H. H. Leukocyte lysozyme activity in myelocytic leukemia. Blood. 1967 Oct;30(4):465–473. [PubMed] [Google Scholar]
  22. Osserman E. F., Lawlor D. P. Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia. J Exp Med. 1966 Nov 1;124(5):921–952. doi: 10.1084/jem.124.5.921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. PROCKOP D. J., DAVIDSON W. D. A STUDY OF URINARY AND SERUM LYSOZYME IN PATIENTS WITH RENAL DISEASE. N Engl J Med. 1964 Feb 6;270:269–274. doi: 10.1056/NEJM196402062700602. [DOI] [PubMed] [Google Scholar]
  24. Piscator M. Proteinuria in chronic cadmium poisoning. 3. Electrophoretic and immunoelectrophoretic studies on urinary proteins from cadmium workers, with special reference to the excretion of low molecular weight proteins. Arch Environ Health. 1966 Mar;12(3):335–344. doi: 10.1080/00039896.1966.10664380. [DOI] [PubMed] [Google Scholar]
  25. Piscator M. Proteinuria in chronic cadmium poisoning. IV. Gel filtration and ion exchange chromatography of urinary proteins from cadmium workers. Arch Environ Health. 1966 Mar;12(3):345–359. doi: 10.1080/00039896.1966.10664381. [DOI] [PubMed] [Google Scholar]
  26. Poulik M. D., Berman L., Prasad A. S. "Myeloma protein" in a patient with monocytic leukemia. Blood. 1969 May;33(5):746–758. [PubMed] [Google Scholar]
  27. Pruzanski W., Saito S. G. The diagnostic value of lysozyme (muramidase) estimation in biological fluids. Am J Med Sci. 1969 Dec;258(6):405–415. doi: 10.1097/00000441-196912000-00005. [DOI] [PubMed] [Google Scholar]
  28. RIESELBACH R. E., BENTZEL C. J., COTLOVE E., FREI E., 3rd, FREIREICH E. J. URIC ACID EXCRETION AND RENAL FUNCTION IN THE ACUTE HYPERURICEMIA OF LEUKEMIA. PATHOGENESIS AND THERAPY OF URIC ACID NEPHROPATHY. Am J Med. 1964 Dec;37:872–883. doi: 10.1016/0002-9343(64)90130-5. [DOI] [PubMed] [Google Scholar]
  29. Roberts R., Makey D. G., Seal U. S. Human transferrin. Molecular weight and sedimentation properties. J Biol Chem. 1966 Nov 10;241(21):4907–4913. [PubMed] [Google Scholar]
  30. Ryder R. J. Chronic monocytic leukaemia. Blut. 1966 Oct;14(1):47–50. doi: 10.1007/BF01633164. [DOI] [PubMed] [Google Scholar]
  31. SINN C. M., DICK F. W. Monocytic leukemia. Am J Med. 1956 Apr;20(4):588–602. doi: 10.1016/0002-9343(56)90140-1. [DOI] [PubMed] [Google Scholar]
  32. Sunderman F. W., Johnson M. W. Studies of the serum proteins. VII. Sucrose gradient electrophoresis. Am J Clin Pathol. 1966 Apr;45(4):381–397. doi: 10.1093/ajcp/45.4.381. [DOI] [PubMed] [Google Scholar]
  33. Sussman M., Asscher A. W., Jenkins J. A. The intrarenal distribution of lysozyme (muramidase). Invest Urol. 1968 Sep;6(2):148–152. [PubMed] [Google Scholar]
  34. Wiernik P. H., Serpick A. A. Clinical significance of serum and urinary muramidase activity in leukemia and other hematologic malignancies. Am J Med. 1969 Mar;46(3):330–343. doi: 10.1016/0002-9343(69)90036-9. [DOI] [PubMed] [Google Scholar]
  35. Wildhack R. Monozytenleukämie mit gamma-G-Paraproteinämie nach Röntgennachbestrahlung und zytostatischer Behandlung eines Myosarkoms. Dtsch Med Wochenschr. 1967 Feb 10;92(6):255–passim. doi: 10.1055/s-0028-1103660. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES